Lyme borreliosis is a prevalent vector-borne disease in the United States, Europe, and parts of Asia, caused the infection with the bacterial pathogen Borrelia burgdorferi. Despite several decades of intense studies, many fundamental aspects of pathogen biology and infection remain largely unknown. B. burgdorferi infection can be difficult to diagnose, and a vaccine to prevent disease in humans is currently unavailable. The application will study how a select set of unique borrelial gene-products BB0323, BBA52 and BBA57 that play important roles in the spirochete infection cycle, contribute to specific aspects of microbial biology and pathogenesis and also assess their potential utility as Lyme disease vaccines. We have four major goals. First, we will examine how a critical virulence determinant of B. burgdorferi, BB0323 undergoes two-step proteolytic processing that ultimately produce distinct N- and C-terminal polypeptides, which play specific roles in cell fission and infectivity. Second, we have discovered that BBA52 is critical for pathogen transmission from ticks to mice and that the protein binds to a receptor in ticks. We propose to study a potential function of BBA52 in vector-pathogen interaction and its role in B. burgdorferi persistence and transmission through ticks. Third, we show that BBA57, a borrelial gene-product important for early spirochete infection in mice, is a major trigger of Lyme arthritis. Our studies will dissect detail molecular and cellular mechanisms of how BBA57 triggers host inflammatory responses and also facilitates spirochete infection. Finally, the proposed study will explore the identification f new vaccine candidates as well as New castle disease virus (NDV) vector-based immunization strategies against Lyme disease. As NDV appears to be safe in humans and is currently in use for therapeutic treatment of cancer patients, the proposed study will establish a foundation for it utility as a possible vaccine vector against human Lyme disease. In sum, these studies will contribute to the understanding of the intriguing biology and infectivity of B. burgdorferi and hel develop novel preventive and therapeutic measures to combat infection.

Public Health Relevance

Lyme disease is a prevalent infection caused by the tick-borne bacterial pathogen Borrelia burgdorferi. We propose to study how a select set of B. burgdorferi antigens that support pathogen persistence contributes to microbial biology, infection and pathogenesis. We also propose to identify novel vaccine targets as well immunization platforms that induce protective host immunity against B. burgdorferi infection.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
2R01AI080615-05A1
Application #
8636247
Study Section
Host Interactions with Bacterial Pathogens Study Section (HIBP)
Program Officer
Breen, Joseph J
Project Start
2009-07-01
Project End
2018-07-31
Budget Start
2014-08-26
Budget End
2015-07-31
Support Year
5
Fiscal Year
2014
Total Cost
$380,000
Indirect Cost
$130,000
Name
University of Maryland College Park
Department
Veterinary Sciences
Type
Schools of Earth Sciences/Natur
DUNS #
790934285
City
College Park
State
MD
Country
United States
Zip Code
20742
Lin, Yi-Pin; Benoit, Vivian; Yang, Xiuli et al. (2014) Strain-specific variation of the decorin-binding adhesin DbpA influences the tissue tropism of the lyme disease spirochete. PLoS Pathog 10:e1004238
Yang, Xiuli; Smith, Alexis A; Williams, Mark S et al. (2014) A dityrosine network mediated by dual oxidase and peroxidase influences the persistence of Lyme disease pathogens within the vector. J Biol Chem 289:12813-22
Yang, Xiuli; Hegde, Shylaja; Shroder, Deborah Y et al. (2013) The lipoprotein La7 contributes to Borrelia burgdorferi persistence in ticks and their transmission to naive hosts. Microbes Infect 15:729-37
Kariu, Toru; Yang, Xiuli; Marks, Carolyn B et al. (2013) Proteolysis of BB0323 results in two polypeptides that impact physiologic and infectious phenotypes in Borrelia burgdorferi. Mol Microbiol 88:510-22
Kung, Faith; Anguita, Juan; Pal, Utpal (2013) Borrelia burgdorferi and tick proteins supporting pathogen persistence in the vector. Future Microbiol 8:41-56
Yang, Xiuli; Qin, Jinhong; Promnares, Kamoltip et al. (2013) Novel microbial virulence factor triggers murine lyme arthritis. J Infect Dis 207:907-18
Ouyang, Zhiming; Narasimhan, Sukanya; Neelakanta, Girish et al. (2012) Activation of the RpoN-RpoS regulatory pathway during the enzootic life cycle of Borrelia burgdorferi. BMC Microbiol 12:44
Hawley, Kelly L; Olson Jr, Chris M; Iglesias-Pedraz, Juan M et al. (2012) CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci U S A 109:1228-32
Lenhart, Tiffany R; Kenedy, Melisha R; Yang, Xiuli et al. (2012) BB0324 and BB0028 are constituents of the Borrelia burgdorferi *-barrel assembly machine (BAM) complex. BMC Microbiol 12:60
Kumar, Manish; Kaur, Simarjot; Kariu, Toru et al. (2011) Borrelia burgdorferi BBA52 is a potential target for transmission blocking Lyme disease vaccine. Vaccine 29:9012-9

Showing the most recent 10 out of 22 publications